JLPC(SH:600513)2015-04-24 16:00Financial Performance - Net profit attributable to shareholders increased by 14.39% to CNY 11,408,968.95 year-on-year[6] - Operating revenue rose by 2.80% to CNY 171,626,978.30 compared to the same period last year[6] - Basic earnings per share increased by 16.67% to CNY 0.07[6] - The weighted average return on equity increased by 0.15 percentage points to 2.60%[6] - Total operating revenue for Q1 2015 was CNY 171,626,978.30, an increase of 2.02% compared to CNY 166,949,440.69 in the same period last year[25] - Net profit for Q1 2015 reached CNY 11,388,830.99, representing a 14.23% increase from CNY 9,967,546.20 in Q1 2014[26] - Total comprehensive income for Q1 2015 was CNY 9,417,228.24, compared to CNY 7,908,485.27 in the same period last year, representing an increase of approximately 19%[28] Assets and Liabilities - Total assets increased by 0.45% to CNY 662,816,713.97 compared to the end of the previous year[6] - The company reported a decrease in net assets attributable to shareholders by 0.44% to CNY 432,014,292.03[6] - The company's current assets totaled CNY 422,835,058.35, compared to CNY 413,706,119.70 at the start of the year, reflecting a growth of approximately 2.73%[19] - The company's total liabilities were CNY 230,494,766.04, up from CNY 224,706,247.41, representing a growth of about 2.5%[21] - Total liabilities for Q1 2015 were CNY 111,013,355.80, an increase from CNY 106,809,445.96 in the previous quarter[24] Cash Flow - Net cash flow from operating activities decreased significantly by 692.20% to -CNY 7,623,343.75[6] - Cash inflow from operating activities totaled CNY 140,190,845.06, down 13% from CNY 160,771,171.05 in Q1 2014[29] - Cash outflow from operating activities increased to CNY 147,814,188.81, compared to CNY 161,733,467.68 in the same period last year[29] - Cash flow from investing activities was negative CNY 427,035.23, an improvement from negative CNY 922,697.57 in Q1 2014[29] - Cash flow from financing activities generated a net inflow of CNY 14,674,979.05, compared to a net outflow of CNY 2,001,215.53 in the previous year[29] Shareholder Information - The total number of shareholders reached 18,610 at the end of the reporting period[10] - The largest shareholder, Jiangsu Lianhuan Pharmaceutical Group Co., Ltd., holds 40.44% of the shares[10] Management Independence - The company guarantees that its financial department and accounting system are independent from the parent company[15] - The company ensures the independence of its management and financial personnel from the parent company[15] - The company maintains independent ownership and operation of its assets, including production systems and facilities[15] - The company has committed to maintaining independent financial operations and governance structures, ensuring no interference from the controlling group[17] Forecasts and Commitments - The profit forecasts for the target assets for 2013, 2014, and 2015 are RMB 6.5436 million, RMB 6.7759 million, and RMB 7.0451 million respectively[14] - The company guarantees that the actual net profits for the target assets will not be less than the above profit forecasts for 2013, 2014, and 2015[14] - There are no significant changes expected in net profit compared to the previous year, indicating stability in financial performance[17] Other Financial Metrics - Non-recurring losses totaled CNY -106,125.86 during the reporting period[8] - The company reported an investment income of CNY 1,413,426.42, up from CNY 947,613.95 in the same period last year[26] - Sales expenses for Q1 2015 were CNY 55,530,931.80, compared to CNY 48,849,091.74 in Q1 2014, indicating a rise of 13.8%[26] - The company’s total equity as of Q1 2015 was CNY 421,409,961.05, down from CNY 425,312,248.88 in the previous quarter[24] - The company’s cash and cash equivalents increased to CNY 54,624.91 from CNY 132,624.91 in the previous quarter[24]